<div style="width: 100%; height: 500px; margin: 20px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; position: relative; z-index: 1;">
    <iframe 
        src="https://s.tradingview.com/widgetembed/?symbol=LLY&interval=D&theme=Light&style=1&locale=en&toolbarbg=f1f3f6&hideideas=1&studies=%5B%22MASimple%40tv-basicstudies%22%2C%20%22MACD%40tv-basicstudies%22%5D" 
        style="width: 100%; height: 100%; border: 0; display: block;" 
        scrolling="no" 
        allowtransparency="true" 
        frameborder="0">
    </iframe>
</div>

📊 TECHNICAL DEEP DIVE (Multi-Timeframe Analysis) A. TREND STRUCTURE (The "Big Picture") - MA System: On the weekly chart, the trend is Bullish as indicated by the price being above the Weekly MA20. However, on the daily chart, the price is below the Daily MA20, suggesting a Bearish market phase. - Bollinger Bands: The daily Bollinger Bands show a width of 6.34, with the price positioned between the upper and lower bands, indicating a neutral stance. The weekly volatility profile shows a current HV of 29.67%, which is within the normal range. B. MOMENTUM & MONEY FLOW (The "Engine") - MACD: The weekly MACD histogram is positive at 11.479, indicating strengthening momentum. In contrast, the daily MACD histogram is negative at -7.336, suggesting weakening momentum. - RSI & KDJ: The daily RSI(14) is 46.03, which is neutral, while the KDJ (J) is 12.22, indicating a potential trend reversal. - OBV (Volume): No explicit volume data is provided, but the ATR (Volatility) is 31.70 on the daily chart, suggesting moderate volatility. - ATR (Volatility): The daily ATR is 31.70, and the intraday ATR is 9.82, indicating varying levels of volatility across different time frames. C. VERDICT: The technical outlook for Eli Lilly is mixed, with a Bullish weekly trend contrasting with a Bearish daily market phase, suggesting a potential pullback or consolidation. 🎯 QUANT SCORE (2-4 Weeks View) [LONG SCORE: 45] [SHORT SCORE: 55] 🚀 STRATEGY & RISK MANAGEMENT - Action: Enter with caution, considering the mixed technical signals. - Levels: Support at around 1010.76 (lower Bollinger Band) and resistance at 1081.39 (upper Bollinger Band). - Option Play: Given the moderate volatility, a neutral strategy such as an iron condor could be considered, selling spreads to capitalize on time decay while managing risk. 🧐 ASSET PROFILE (Fundamental Context) - Identity: Eli Lilly (LLY) is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products worldwide. Its business model includes the development and commercialization of a wide range of pharmaceutical products, including diabetes, oncology, immunology, and neuroscience treatments. - Status/Holdings: As of the latest data, Eli Lilly's recent profitability/earnings trend shows a need for analysis based on the latest financial reports, which are not provided here. The PE/Valuation status, given the current market price of 1038.40, would need to be assessed against the industry average and its historical PE range to determine if it's relatively expensive or cheap. However, with a current HV of 29.67%, volatility is within a normal range, suggesting that options might not be overly expensive or cheap based solely on historical volatility.